Healthcare Services Group, Inc. — 2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This is an annual filing; the supplied filing text does not provide standalone fourth-quarter results.
Business context
Healthcare Services Group provides housekeeping, laundry, linen, facility maintenance and dietary management services to healthcare facilities in the United States. At year-end it served approximately 2,700 facilities through two reportable segments: Housekeeping and Dietary. Most customer agreements renew annually and may be cancelled on 30 to 90 days’ notice after an initial period.
Financial performance
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $1,671.4 million | $1,690.2 million | (1.1%) |
| Income before taxes | $53.1 million | $44.6 million | +19.1% |
| Net income | $38.4 million | $34.2 million | +12.1% |
| Diluted EPS | $0.52 | $0.46 | +13.0% |
| Operating cash flow | $43.5 million | $(8.2) million | Improved |
- Net margin was 2.2% of revenue, versus 2.0% in 2022. Costs of services were 87.2% of revenue, compared with 88.6%.
- Housekeeping revenue was $766.7 million, down 3.6%, chiefly reflecting fewer facilities served. Segment income before taxes was $61.3 million, down 16.1%.
- Dietary revenue was $904.7 million, up 1.1%, despite fewer facilities served; contractual pass-throughs of labor and food costs contributed. Segment income before taxes was $43.5 million, up 49.8%.
- SG&A rose 18.8% to $166.8 million, including a $15.9 million year-over-year swing in deferred-compensation investment results; excluding that effect, SG&A increased 7.1%. Investment and other income improved to $12.9 million from a $5.4 million loss, while interest expense rose to $7.9 million from $3.0 million.
- Bad debt provision increased to $35.6 million from $32.0 million, equal to 2.1% of revenue versus 1.9%. Net accounts and notes receivable were $408.3 million; the allowance for doubtful accounts was $91.7 million across short- and long-term receivables.
Liquidity, debt and capital allocation
- Cash, cash equivalents and marketable securities totaled $147.5 million at year-end, versus $121.5 million a year earlier. Working capital was $354.8 million, up from $319.6 million; the current ratio was 2.6 in both years.
- Borrowings under the $300 million revolving credit facility were $25.0 million. Availability after $85.9 million of standby letters of credit was $189.1 million. The company reported compliance with its covenants: funded debt/EBITDA of 0.97 versus a maximum of 3.50, and EBITDA/interest expense of 9.92 versus a minimum of 3.00. The facility expires November 22, 2027.
- Operating cash flow included a $44.2 million cash use from changes in operating assets and liabilities, driven primarily by higher accounts and notes receivable. Capital expenditures were $5.4 million.
- The company suspended its quarterly dividend in February 2023 and repurchased 1.0 million shares for $11.1 million during the year. Management estimated 2024 capital expenditures of $4.0 million to $6.0 million and stated that available cash, operating cash flow and credit capacity should fund operations and anticipated growth.
Material changes, outlook and risks
- Revenue declined modestly, but pretax and net income increased, aided by lower consolidated service costs and more favorable investment results. Housekeeping profitability weakened while Dietary profitability improved.
- A $13.8 million revenue reduction in 2023 reflected an estimated price concession related to a customer’s out-of-court restructuring. The comparable 2022 revenue reduction was $10.0 million.
- Management’s stated priorities include winning new customers, retaining and expanding existing relationships, seeking modest price increases and controlling costs. No specific consolidated revenue or earnings guidance was provided.
- Key business risks include customer credit and collections, dependence on Medicare and Medicaid funding at customers, labor and supply inflation, short-notice contract termination, self-insured claims estimates, and reliance on Sysco for more than half of food and non-food dining supply distribution.
- Genesis Healthcare accounted for 10.9% of 2023 revenue. At year-end, HCSG had $61.8 million of Genesis accounts receivable and $20.4 million of notes receivable. A substantial revenue reduction or collection delay could materially affect results and cash flow.
- Management and the auditor identified a material weakness in controls over accrued payroll liabilities for vested vacation. The weakness contributed to immaterial errors in 2021 and 2022 financial statements, which were corrected in this filing. The auditor issued an adverse opinion on internal control effectiveness, but an unqualified opinion on the financial statements. Remediation steps are underway; effectiveness is not yet established.
- Some pending litigation losses could not be reasonably estimated. The filing says management did not expect legal matters, individually or in aggregate, to materially affect financial position or results, but outcomes remain uncertain.
Important facts for investors to verify
- Whether the accrued-vacation control weakness is fully remediated and controls operate effectively over a sufficient period.
- Genesis’s restructuring, payment performance, receivable recoverability and the expected effect of the $13.8 million concession.
- Receivables aging, allowance adequacy and subsequent collections, particularly given the rising bad-debt provision and receivable balance.
- Whether segment facility counts, customer retention and pricing pass-throughs support revenue and margin trends as labor and food costs fluctuate.
- Actual liquidity and covenant headroom, including use of the revolving facility and the insurance-related letters of credit.
- Developments in pending litigation, self-insurance reserves and the unrecognized Employee Retention Credit claim; the company had received no refund or IRS correspondence through February 16, 2024 and recognized no ERC benefit.